+1-888-308-5802     
News Contact Us

Antidiabetics Market 2020 growth factors, latest trend and regional analysis of leading players by 2026

Author : Ronak Bora | Published Date : 2020-09-02 

Antidiabetics Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Rise in number of obese and diabetic patients worldwide is touted to impel the antidiabetics market share over the forthcoming years. Geriatric population across the globe are mostly diagnosed with diabetes. In fact, a report from WHO (World Health Organization) claims that about 422 million people across the world are diagnosed with diabetes with more than 1.6 million deaths. In a bid to offer better treatment options to help decrease this high mortality rate, the production of antidiabetics may surge significantly over the coming years. Based on these factors, GMI, estimates the global antidiabetics market may grow at a CAGR of about 10.7% over 2026. In 2019, the industry was valued at over $65.5 billion in 2019.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/504

The insulin product segment was accounted for the highest market revenue share in 2019. The product is touted to witness significant demand over the forecast timespan primarily due to the surging number of patients suffering from type 2 diabetes.

Rising use of several advanced therapies to receive better results should increase product preference among consumers. Increasing funding by industry players in research and development of new products would bolster segment share. Estimates suggest that the segment may register a healthy CAGR of more than 12.0% by 2026.

Increasing number of diabetes patients as well as growing geriatric population are likely to fuel the Europe antidiabetics market trends. In 2019, Europe accounted for over 32% of the entire market share. The industry is expected to observe substantial growth since major industry players are foraying to expand their footprint in this revenue-rich avenue.

With the increasing patient population, major market players are focusing on various expansion strategies such as partnerships, acquisitions, new product launches, and investments. Citing an instance, in September 2019, the U.S. FDA authorized a new antidiabetic Rybelsus. Rybelsus is developed by Novo Nordisk for the treatment of patients with type 2 diabetes. The competitive landscape of the global antidiabetics market is also inclusive of players such as Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Corporation, and AstraZeneca among others. 

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/antidiabetics-market

Partial Chapter of the Table of Content 

Chapter 4. Antidiabetics Market, By Product

4.1. Key segment trends

4.2. Insulin

4.2.1.  Market size, by region, 2015 - 2026 (USD Million)

4.2.2.  Rapid acting analog

4.2.2.1.  Market size, by region, 2015-2026 (USD Million)

4.2.3.  Long acting analog

4.2.3.1.  Market size, by region, 2015-2026 (USD Million)

4.2.4.  Premixed insulin

4.2.4.1.  Market size, by region, 2015-2026 (USD Million)

4.2.5.  Short acting analog

4.2.5.1.  Market size, by region, 2015-2026 (USD Million)

4.2.6.  Intermediate acting analog

4.2.6.1.  Market size, by region, 2015-2026 (USD Million)

4.3. Drug class

4.3.1.  Market size, by region, 2015 - 2026 (USD Million)

4.3.2.  Alpha glucosidase inhibitors

4.3.2.1.  Market size, by region, 2015-2026 (USD Million)

4.3.3.  Biguanides

4.3.3.1.  Market size, by region, 2015-2026 (USD Million)

4.3.4.  Sulphonylureas

4.3.4.1.  Market size, by region, 2015-2026 (USD Million)

4.3.5.  GLP-1 (Glucagon like peptide) agonists

4.3.5.1.  Market size, by region, 2015-2026 (USD Million)

4.3.6.  DPP-IV (Dipeptidyl Peptidase) inhibitors

4.3.6.1.  Market size, by region, 2015-2026 (USD Million)

4.3.7.  Meglitinides

4.3.7.1.  Market size, by region, 2015-2026 (USD Million)

4.3.8.  SGLT-II (Sodium Glucose Transport Proteins) inhibitors

4.3.8.1.  Market size, by region, 2015-2026 (USD Million)

4.3.9.  Thiazolidinedione

4.3.9.1.  Market size, by region, 2015-2026 (USD Million)

Chapter 5. Antidiabetics Market, By Patient Population

5.1. Key segment trends

5.2. Pediatric

5.2.1.  Market size, by region, 2015 - 2026 (USD Million)

5.3. Adult

5.3.1.  Market size, by region, 2015 - 2026 (USD Million)

5.4. Geriatric

5.4.1.  Market size, by region, 2015 - 2026 (USD Million)

Chapter 6. Antidiabetics Market, By Route of Administration

6.1. Key segment trends

6.2. Insulin syringe/ Insulin pen

6.2.1.  Market size, by region, 2015 - 2026 (USD Million)

6.3. Insulin pump

6.3.1.  Market size, by region, 2015 - 2026 (USD Million)

6.4. Intravenous infusion

6.4.1.  Market size, by region, 2015 - 2026 (USD Million)

6.5. Oral

6.5.1.  Market size, by region, 2015 - 2026 (USD Million)

6.6. Others

6.6.1.  Market size, by region, 2015 - 2026 (USD Million)

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

Therapeutic Vaccines Market COVID-19 Impact Analysis, Trends, Business Growth & Forecast 2020-2026

Published Date: 2020-09-30         Author: Ronak Bora

The therapeutic vaccines market report encompasses an in-depth analysis of the business space in question. All the growth facilitators responsible for furling the revenue scope of this industry are mentioned in the study in conjunction with the competitive and geographical trends character... Read More

Home Healthcare Software Market Revenue Forecast 2020-2026 By Regional Manufacturers

Published Date: 2020-09-30         Author: Ronak Bora

The home healthcare software market research study is a detailed document that presents a gist of the global industry space in terms of numerous parameters. Some of these fall along the likes of the industry insights, growth drivers, industry segmentation, and trends worldwide. Also includ... Read More

Minimally Invasive Female Urinary Incontinence Devices Market 2020 By Industry Trends & Regional Forecast To 2026

Published Date: 2020-09-30         Author: Ronak Bora

A detailed analysis of the minimally invasive female urinary incontinence devices market is entailed in this research report. The driving forces responsible for propelling the growth graph of this vertical in addition to the regional and competitive trends are mentioned in the st... Read More

© 2020 Fractovia. All Rights Reserved